One Onslow Street
Sanofi-aventis is the worldâ€™s 3rd largest pharmaceutical company and ranks number 1 in Europe, with around 100,000 employees worldwide. Global headquarters are located in Paris, France and the U.K. headquarters are in Guildford, Surrey.
Seven major therapeutic areas
Sanofi-aventis focuses its activities on seven major therapeutic areas:
- internal medicine
- metabolic disorders
- diseases of the central nervous system
- and vaccines
Great medicines for millions of patients
The sanofi-aventis portfolio of marketed products contains several medicines that are world leaders in their respective classes including: ClexaneÂ® (enoxaparin sodium), PlavixÂ® (clopidogrel bisulfate), TelfastÂ® (fexofenadine), AprovelÂ® (irbesartan), Eloxatinâ„˘ (oxaliplatin), LantusÂ® (insulin glargine), ActonelÂ® (risedronate sodium) and TaxotereÂ® (docetaxel).
A highly productive and innovation R&D organisation
Sanofi-aventis is an industry-leading R&D organisation that is comprised of over 17,000 research staff working in over 20 research centres around the world. Sanofi-aventis maintains its commitment to creating innovative therapeutic treatments and has devoted over four billion euros to its current portfolio that includes over 48 compounds presently in advanced stages of development.
For more information about sanofi-aventis worldwide, visit www.sanofi-aventis.com.